Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilitiesByAbigail Lewis, Content InternJune 24th 2026
IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLsByDouglas D. Koch, MD,Karolinne Maia Rocha, MD, PhDJune 18th 2026
TECNIS PureSee IOL launches in US following FDA approval for cataract surgeryByOphthalmology Times StaffJune 11th 2026
Positive Topline Results, Promising Future for Bimatoprost Drug Pad-IOL System, With Fiaz Zaman, MDByFiaz Zaman, MDApril 16th 2026
Modular, Shape-Changing IOL for Presbyopia Improves Vision at 36 Months, Demonstrates Lasting EffectsByRyan LivingstonApril 15th 2026